[Mid-term efficacy of China Net Childhood Lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma]
- Resource Type
- Authors
- M, Zhang; P, Wu; Y L, Duan; L, Jin; J, Yang; S, Huang; Y, Liu; B, Hu; X W, Zhai; H S, Wang; Y, Fu; F, Li; X M, Yang; A S, Liu; S, Qin; X J, Yuan; Y S, Dong; W, Liu; J W, Zhou; L P, Zhang; Y P, Jia; J, Wang; L J, Qu; Y P, Dai; G T, Guan; L R, Sun; J, Jiang; R, Liu; R M, Jin; Z J, Wang; X G, Wang; B X, Zhang; K L, Chen; S Q, Zhuang; J, Zhang; C J, Zhou; Z F, Gao; M C, Zheng; Yonghong, Zhang
- Source
- Zhonghua er ke za zhi = Chinese journal of pediatrics. 60(10)
- Subject
- Male
Lymphoma, B-Cell
Adolescent
Prognosis
Burkitt Lymphoma
Disease-Free Survival
Treatment Outcome
Antineoplastic Combined Chemotherapy Protocols
Humans
Female
Child
Rituximab
Lactate Dehydrogenases
Retrospective Studies
- Language
- ISSN
- 0578-1310